A significant decrease of VEGF levels between day 0 and 2 could be detected in patients with no remaining tumor (p = 0.001) and patients with remaining tumor <1 cm (p = 0.009), but not in patients with residual tumor >1 cm (p = 0.499). This evidence concerns the gene VEGFA and neoplasm.